psychedelics investing Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
psychedelics investing Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training
psychedelics investing Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training
psychedelics investing Compass Pathways to Participate in Investor Conferences the Week of September 14th
psychedelics investing Compass Pathways' New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year
psychedelics investing Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
psychedelics investing Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026
psychedelics investing Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026
psychedelics investing Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2025 Results and Provides Corporate Update
psychedelics investing The Calmer Co. Secures Exclusive Global Distribution Agreement for Kava Extract Ingredients up to $25 million
psychedelics investing Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026
psychedelics investing Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin
psychedelics investing Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026
Silver Hammer Plans a Fall Surface and Drilling Exploration Program at the Silver Strand Project in Idaho, USA
Blue Jay Gold Intersects 14.0 m of 6.15 g/t Gold and 124 g/t Silver at Skukum Creek, Including 10.5 m of 7.84 g/t Gold and 154 g/t Silver
